Biofrontera Inc (BFRI) Stock Price, Quote & News

Company Profile

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatmen...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 781 245 1325

Website: www.biofrontera-us.com

Address:

120 Presidential Way, Suite 330, Woburn, United States

Bulltrader988 Oct. 4 at 12:50 PM

$BFRI more and more interesting 👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d

0 · Reply

Bulltrader988 Oct. 3 at 7:42 AM

$BFRI interesting spot 👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d

0 · Reply

HouseOfTheDragons Oct. 3 at 2:59 AM

Looks like volume & momentum could be shifting in to ASTC! Tiny float getting a lot of attention and could explode upwards on volume. Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $HSDT $BFRI $DOGZ $TC $TVGN news

0 · Reply

Bulltrader988 Oct. 1 at 9:53 PM

$BFRI chart looks good 👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d

0 · Reply

ivo98 Sep. 30 at 10:26 AM

$BFRI Dieses Wachstum kann jedoch nicht linear betrachtet werden, da im ersten Halbjahr 2024 aufgrund einer Änderung der Lagerhaltungspolitik von Biofrontera Inc. keine Ameluz®-Verkäufe an unseren US-Partner getätigt wurden. Sämtliche Umsätze in diesem Zeitraum entfielen ausschließlich auf Lampenverkäufe sowie den Verkauf von Mustern. Ab dem vierten Quartal 2024 begann Biofrontera Inc. jedoch, sein übliches Ameluz®-Bestellvolumen wieder aufzunehmen, ein Trend, der sich im ersten Halbjahr 2025 fortsetzte.

0 · Reply

Hard2beLong Sep. 29 at 10:45 PM

$BFRI well done! No one yet noticed it.. tomorrow will add here

2 · Reply

ivo98 Sep. 28 at 7:13 AM

$BFRI has nothing to do with Bfri. These are Bfra shares (Biofrontera AG).

0 · Reply

Bulltrader988 Sep. 27 at 7:38 PM

$BFRI Form 3 filled yesterday 👃👀 DEUTSCHE BALATON AKTIENGESELLSCHAFT.. "...Explanation of Responses: 1. The reported shares are held directly by Biofrontera AG. The Reporting Person and its affiliates collectively hold approximately 62.2% of the outstanding voting stock of Biofrontera AG and therefore may be deemed to beneficially own the shares owned by Biofrontera AG. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose...." 👃👀 https://www.sec.gov/Archives/edgar/data/1571071/000121390025092403/xslF345X02/ownership.xml

0 · Reply

ivo98 Sep. 26 at 7:16 PM

$BFRI why don't we see the executed orders in the graphics on Nasdaq, Yahoo finance and Webull?

0 · Reply

Bulltrader988 Sep. 26 at 6:42 PM

$BFRI "... announced that it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2025 Investor Conference, taking place virtually on Tuesday, September 30, 2025... The webcast presentation will take place at 1:15 p.m. ET on Tuesday, September 30, 2025...." 👃👀 https://www.stocktitan.net/news/BFRI/biofrontera-inc-to-participate-in-the-lytham-partners-fall-2025-452xl1zslnis.html

0 · Reply

Biofrontera Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

Sep 23, 2025, 9:20 AM EDT - 11 days ago

Biofrontera Inc. Engages Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication Program

Sep 16, 2025, 10:30 AM EDT - 18 days ago

Biofrontera Inc. Announces Last Patient Out in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Photodynamic Therapy (PDT) for the Treatment of Actinic Keratoses (AK) on the Extremities, Neck and Trunk

Aug 25, 2025, 8:25 AM EDT - 5 weeks ago

Biofrontera Inc. Announces Last-Patient-Out in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris

Aug 14, 2025, 12:36 PM EDT - 7 weeks ago

Biofrontera Inc. (BFRI) Q2 2025 Earnings Conference Call Transcript

Aug 13, 2025, 5:20 PM EDT - 7 weeks ago

Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update

Aug 11, 2025, 4:25 PM EDT - 7 weeks ago

Biofrontera Inc. Appoints George Jones as Chief Commercial Officer

Aug 4, 2025, 2:00 PM EDT - 2 months ago

Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025

Jun 30, 2025, 8:00 AM EDT - 3 months ago

Biofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By $11 Million Investment

Jun 11, 2025, 3:00 PM EDT - 4 months ago

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

Jun 3, 2025, 2:30 PM EDT - 4 months ago

Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book

May 16, 2025, 3:36 PM EDT - 5 months ago

Biofrontera Inc. (BFRI) Q1 2025 Earnings Call Transcript

May 15, 2025, 5:09 PM EDT - 5 months ago

Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update

May 15, 2025, 12:17 PM EDT - 5 months ago

Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris

May 6, 2025, 12:45 PM EDT - 5 months ago

Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025

May 1, 2025, 2:38 PM EDT - 5 months ago

Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis

Mar 21, 2025, 11:20 AM EDT - 7 months ago

Biofrontera Inc. (BFRI) Q4 2024 Earnings Call Transcript

Mar 21, 2025, 8:00 AM EDT - 7 months ago

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update

Mar 18, 2025, 9:30 AM EDT - 7 months ago

Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and Trunk

Mar 11, 2025, 10:00 AM EDT - 7 months ago

Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025

Jan 8, 2025, 9:50 AM EST - 9 months ago

Biofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

Dec 23, 2024, 9:30 AM EST - 10 months ago

Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market

Dec 3, 2024, 11:00 AM EST - 10 months ago

Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Nov 22, 2024, 9:10 AM EST - 11 months ago

Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note

Nov 14, 2024, 3:02 PM EST - 11 months ago

Biofrontera Inc. (BFRI) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 5:15 PM EST - 11 months ago

Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update

Nov 1, 2024, 11:55 AM EDT - 1 year ago

Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024

Oct 31, 2024, 10:32 AM EDT - 1 year ago

Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

Oct 14, 2024, 10:30 AM EDT - 1 year ago

Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

Oct 7, 2024, 8:45 AM EDT - 1 year ago

FDA Approves Use of Up To Three Tubes of Biofrontera Inc.'s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment

Sep 25, 2024, 10:45 AM EDT - 1 year ago

Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference

Aug 15, 2024, 1:34 PM EDT - 1 year ago

Biofrontera Inc. (BFRI) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:30 PM EDT - 1 year ago

Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update

Aug 9, 2024, 10:00 AM EDT - 1 year ago

Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024

Jun 24, 2024, 8:30 AM EDT - 1 year ago

Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp

May 16, 2024, 2:44 PM EDT - 1 year ago

Biofrontera Inc. (BFRI) Q1 2024 Earnings Call Transcript

May 15, 2024, 4:45 PM EDT - 1 year ago

Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update

May 6, 2024, 10:30 AM EDT - 1 year ago

Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024

May 3, 2024, 8:50 AM EDT - 1 year ago

Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants

Mar 26, 2024, 4:30 PM EDT - 1 year ago

Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals

Mar 18, 2024, 12:13 PM EDT - 1 year ago

Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript

Mar 15, 2024, 8:25 PM EDT - 1 year ago

CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update

Mar 15, 2024, 6:10 PM EDT - 1 year ago

Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update

Mar 8, 2024, 9:00 AM EST - 1 year ago

Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024

Mar 5, 2024, 7:30 AM EST - 1 year ago

Medicus Pharma Ltd. Announces Appointment of Erica Monaco as Chief Operating Officer

Feb 23, 2024, 8:40 AM EST - 1 year ago

Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules

Feb 20, 2024, 8:10 AM EST - 1 year ago

Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG

Feb 20, 2024, 8:05 AM EST - 1 year ago

Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules

Feb 5, 2024, 5:15 PM EST - 1 year ago

Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use

Jan 11, 2024, 4:15 PM EST - 1 year ago

Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023

Bulltrader988 Oct. 4 at 12:50 PM

$BFRI more and more interesting 👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d

0 · Reply

Bulltrader988 Oct. 3 at 7:42 AM

$BFRI interesting spot 👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d

0 · Reply

HouseOfTheDragons Oct. 3 at 2:59 AM

0 · Reply

Bulltrader988 Oct. 1 at 9:53 PM

$BFRI chart looks good 👃👀 https://finviz.com/quote.ashx?t=BFRI&ty=c&ta=1&p=d

0 · Reply

ivo98 Sep. 30 at 10:26 AM

0 · Reply

Hard2beLong Sep. 29 at 10:45 PM

$BFRI well done! No one yet noticed it.. tomorrow will add here

2 · Reply

ivo98 Sep. 28 at 7:13 AM

$BFRI has nothing to do with Bfri. These are Bfra shares (Biofrontera AG).

0 · Reply

Bulltrader988 Sep. 27 at 7:38 PM

0 · Reply

ivo98 Sep. 26 at 7:16 PM

$BFRI why don't we see the executed orders in the graphics on Nasdaq, Yahoo finance and Webull?

0 · Reply

Bulltrader988 Sep. 26 at 6:42 PM

0 · Reply

ivo98 Sep. 25 at 9:52 AM

$BFRI https://www.hcplive.com/view/spotlighting-data-clearance-actinic-keratosis-using-tirbanibulin-neal-bhatia-md

0 · Reply

nomen Sep. 23 at 9:54 PM

$BFRI Using a diluted share count of 30mm and 200mm+ peak sales estimates including sBCC and improving unit economics and patent protection till 2043 tell me how this isn’t at least $10 in a few years

1 · Reply

Bulltrader988 Sep. 23 at 1:50 PM

$BFRI 👃👀 https://www.stocktitan.net/news/BFRI/biofrontera-inc-engages-lytham-partners-to-lead-strategic-investor-v7rfkjxr51ef.html

0 · Reply